Torthaí cuardaigh - David T. Dicker
- 1 - 20 toradh as 37 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
-
2
-
3
Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-... de réir Zhaoyu Jin, E. Robert McDonald, David T. Dicker, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2004Artigo -
4
-
5
Circulating tumor cells: silent predictors of metastasis de réir Lanlan Zhou, David T. Dicker, Elizabeth Matthew, Wafik S. El‐Deiry, R. Katherine Alpaugh
Foilsithe / Cruthaithe 2017Pré-impressão -
6
CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth de réir Noel A. Warfel, Nathan G. Dolloff, David T. Dicker, Jozef Malysz, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2013Artigo -
7
-
8
The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis de réir Rishu Takimoto, Wenge Wang, David T. Dicker, Farzan Rastinejad, Joseph P. Lyssikatos, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2002Artigo -
9
BRCA1 Transcriptionally Regulates Damaged DNA Binding Protein (DDB2) In the DNA Repair Response Following UV-Irradiation de réir Rishu Takimoto, Timothy K. MacLachlan, David T. Dicker, Yoshiro Niitsu, Toshio Mori, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2002Artigo -
10
Direct Repression of <i>FLIP</i> Expression by c-myc Is a Major Determinant of TRAIL Sensitivity de réir M. Ricci, Zhaoyu Jin, Michael Dews, Duonan Yu, Andrei Thomas‐Tikhonenko, David T. Dicker, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2004Artigo -
11
Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab de réir Lori S. Hart, Nathan G. Dolloff, David T. Dicker, Constantinos Koumenis, James G. Christensen, Adda Grimberg, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2011Artigo -
12
miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells de réir Amriti R. Lulla, Michael Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2017Artigo -
13
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases de réir Akshal Patel, Joshua E. Allen, David T. Dicker, Kristi L. Peters, Jonas M. Sheehan, Michael Glantz, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2011Artigo -
14
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway de réir Joshua E. Allen, Gabriel Krigsfeld, Luv Patel, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2015Artigo -
15
Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation de réir Varun V. Prabhu, Bo Hong, Joshua E. Allen, Shengliang Zhang, Amriti R. Lulla, David T. Dicker, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2016Artigo -
16
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death de réir Kageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, Jing Xu, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2008Artigo -
17
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth, and chemosensitivity under hypoxic conditions de réir Elizabeth Matthew, Lori S. Hart, Aristotelis Astrinidis, Arunasalam Navaraj, Nathan G. Dolloff, David T. Dicker, Elizabeth P. Henske, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2009Artigo -
18
Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells de réir Seok‐Hyun Kim, Kunhong Kim, Jae Kwagh, David T. Dicker, Meenhard Herlyn, Anil K. Rustgi, Youhai Chen, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2004Artigo -
19
Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53 de réir Bo Hong, Varun V. Prabhu, Shengliang Zhang, A. Pieter J. van den Heuvel, David T. Dicker, Levy Kopelovich, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2013Artigo -
20
Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis de réir Junaid Abdulghani, Joshua E. Allen, David T. Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D. Smith, Robin Humphreys, Wafik S. El‐Deiry
Foilsithe / Cruthaithe 2013Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Cancer research
Biology
Biochemistry
Cancer
Medicine
Chemistry
Apoptosis
Cell biology
Internal medicine
Gene
Genetics
Pharmacology
Cell cycle
Colorectal cancer
Programmed cell death
Breast cancer
Cancer cell
Immunology
Kinase
Molecular biology
Oncology
Hepatocellular carcinoma
Sorafenib
Tumor necrosis factor alpha
Cell
Cell culture
Circulating tumor cell
Downregulation and upregulation
Metastasis
Metastatic breast cancer